Oxurion (OXUR.BR) Stock Price

Oxurion Price

Euronext Brussels·CLOSED
0.00EUR-0.0002 (-7.41 %)
Market closed

Revenue at Oxurion has contracted by 33.0% per year over the past 19 years to 3,000.00 EUR. Earnings per share have declined at 14.4% per year over the last 16 years. Oxurion's net margin stands at 3,966.7%, up from -1,348.0% several years earlier. Analysts set a median price target of 0.27 EUR, implying 10,100.0% above the current price. Of 9 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 8% above its 52-week low.

Oxurion stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Oxurion over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Oxurion stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Oxurion's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Oxurion Stock Price History
DateOxurion Price
8/5/20260.00 EUR
8/4/20260.00 EUR
7/31/20260.00 EUR
7/30/20260.00 EUR
7/29/20260.00 EUR
7/28/20260.00 EUR
7/27/20260.00 EUR
7/24/20260.00 EUR
7/23/20260.00 EUR
7/22/20260.00 EUR
7/21/20260.00 EUR
7/20/20260.00 EUR
7/17/20260.00 EUR
7/15/20260.00 EUR
7/14/20260.00 EUR
7/13/20260.00 EUR
7/10/20260.00 EUR
7/9/20260.00 EUR
7/8/20260.00 EUR
7/7/20260.00 EUR
7/6/20260.00 EUR
7/3/20260.00 EUR
7/2/20260.00 EUR
7/1/20260.00 EUR
6/30/20260.00 EUR
6/29/20260.00 EUR
6/26/20260.00 EUR
6/25/20260.00 EUR
6/24/20260.00 EUR
6/23/20260.00 EUR
6/22/20260.00 EUR
6/19/20260.00 EUR
6/18/20260.00 EUR
6/17/20260.00 EUR
6/16/20260.00 EUR
6/15/20260.00 EUR
6/12/20260.00 EUR
6/11/20260.00 EUR
6/10/20260.00 EUR
6/9/20260.00 EUR
6/8/20260.00 EUR
6/5/20260.00 EUR
6/4/20260.00 EUR
6/3/20260.00 EUR
6/2/20260.00 EUR
6/1/20260.00 EUR
5/29/20260.00 EUR
5/28/20260.00 EUR
5/27/20260.00 EUR
5/26/20260.00 EUR
5/25/20260.00 EUR
5/22/20260.00 EUR
5/21/20260.00 EUR
5/20/20260.00 EUR
5/19/20260.00 EUR
5/18/20260.00 EUR
5/15/20260.00 EUR
5/14/20260.00 EUR
5/13/20260.00 EUR
5/12/20260.00 EUR
5/11/20260.00 EUR
5/8/20260.00 EUR
5/7/20260.00 EUR
5/6/20260.00 EUR
5/5/20260.00 EUR
5/4/20260.00 EUR
4/30/20260.00 EUR
4/29/20260.00 EUR
4/28/20260.00 EUR
4/27/20260.00 EUR
4/24/20260.00 EUR
4/23/20260.00 EUR
4/22/20260.00 EUR
4/21/20260.00 EUR
4/20/20260.00 EUR
4/17/20260.00 EUR
4/16/20260.00 EUR
4/15/20260.00 EUR
4/14/20260.00 EUR
4/13/20260.00 EUR
4/10/20260.00 EUR
4/9/20260.00 EUR
4/8/20260.00 EUR
4/7/20260.00 EUR
4/2/20260.00 EUR
4/1/20260.01 EUR
3/31/20260.01 EUR
3/30/20260.00 EUR
3/27/20260.01 EUR
3/26/20260.01 EUR
3/25/20260.01 EUR
3/24/20260.00 EUR
3/23/20260.01 EUR
3/20/20260.01 EUR
3/19/20260.01 EUR
3/18/20260.01 EUR
3/17/20260.01 EUR
3/16/20260.01 EUR
3/13/20260.01 EUR
3/12/20260.01 EUR
3/11/20260.01 EUR
3/10/20260.01 EUR
3/9/20260.01 EUR
3/6/20260.01 EUR
3/5/20260.01 EUR
3/4/20260.01 EUR
3/3/20260.01 EUR
3/2/20260.01 EUR
2/27/20260.01 EUR
2/26/20260.01 EUR
2/25/20260.01 EUR
2/24/20260.01 EUR
2/23/20260.01 EUR
2/20/20260.01 EUR
2/19/20260.01 EUR
2/18/20260.01 EUR
2/17/20260.01 EUR
2/16/20260.01 EUR
2/13/20260.01 EUR
2/12/20260.01 EUR
2/11/20260.01 EUR
2/10/20260.01 EUR
2/9/20260.01 EUR
2/6/20260.01 EUR
2/5/20260.01 EUR
2/4/20260.01 EUR
2/3/20260.01 EUR
2/2/20260.01 EUR
1/30/20260.01 EUR
1/29/20260.01 EUR
1/28/20260.01 EUR
1/27/20260.01 EUR
1/26/20260.01 EUR
1/23/20260.01 EUR
1/22/20260.01 EUR
1/21/20260.01 EUR
1/20/20260.01 EUR
1/19/20260.01 EUR
1/16/20260.01 EUR
1/15/20260.01 EUR
1/14/20260.01 EUR
1/13/20260.01 EUR
1/12/20260.01 EUR
1/9/20260.01 EUR
1/8/20260.01 EUR
1/7/20260.01 EUR
1/6/20260.01 EUR
1/5/20260.01 EUR
1/2/20260.01 EUR
12/31/20250.01 EUR
12/30/20250.01 EUR
12/29/20250.01 EUR
12/24/20250.01 EUR
12/23/20250.01 EUR
12/22/20250.01 EUR
12/19/20250.01 EUR
12/18/20250.01 EUR
12/17/20250.01 EUR
12/16/20250.01 EUR
12/15/20250.01 EUR
12/12/20250.01 EUR
12/11/20250.01 EUR
12/10/20250.01 EUR
12/9/20250.01 EUR
12/8/20250.01 EUR
12/5/20250.01 EUR
12/4/20250.01 EUR
12/3/20250.01 EUR
12/2/20250.01 EUR
12/1/20250.01 EUR
11/28/20250.01 EUR
11/27/20250.01 EUR
11/26/20250.01 EUR
11/25/20250.01 EUR
11/24/20250.01 EUR
11/21/20250.01 EUR
11/20/20250.01 EUR
11/19/20250.01 EUR
11/18/20250.01 EUR
11/17/20250.01 EUR
11/14/20250.01 EUR
11/13/20250.01 EUR
11/12/20250.01 EUR
11/11/20250.01 EUR
11/10/20250.01 EUR
11/7/20250.01 EUR
11/6/20250.01 EUR
11/5/20250.01 EUR
11/4/20250.01 EUR
11/3/20250.01 EUR
10/31/20250.01 EUR
10/30/20250.01 EUR
10/29/20250.01 EUR
10/28/20250.01 EUR
10/27/20250.01 EUR
10/24/20250.01 EUR
10/23/20250.01 EUR
10/22/20250.02 EUR
10/21/20250.02 EUR
10/20/20250.01 EUR
10/17/20250.02 EUR
10/16/20250.02 EUR
10/15/20250.02 EUR
10/14/20250.02 EUR
10/13/20250.02 EUR
10/10/20250.02 EUR
10/9/20250.02 EUR
10/8/20250.02 EUR
10/7/20250.02 EUR
10/6/20250.02 EUR
10/3/20250.02 EUR
10/2/20250.02 EUR
10/1/20250.02 EUR
9/30/20250.02 EUR
9/29/20250.02 EUR
9/26/20250.02 EUR
9/25/20250.02 EUR
9/24/20250.02 EUR
9/23/20250.02 EUR
9/22/20250.02 EUR
9/19/20250.02 EUR
9/18/20250.02 EUR
9/17/20250.02 EUR
9/16/20250.02 EUR
9/15/20250.02 EUR
9/12/20250.02 EUR
9/11/20250.02 EUR
9/10/20250.02 EUR
9/9/20250.02 EUR
9/8/20250.02 EUR
9/5/20250.02 EUR
9/4/20250.02 EUR
9/3/20250.02 EUR
9/2/20250.02 EUR
9/1/20250.02 EUR
8/29/20250.02 EUR
8/28/20250.02 EUR
8/27/20250.02 EUR
8/26/20250.02 EUR
8/25/20250.03 EUR
8/22/20250.03 EUR
8/21/20250.02 EUR
8/20/20250.03 EUR
8/19/20250.03 EUR
8/18/20250.02 EUR
8/15/20250.02 EUR
8/14/20250.02 EUR
8/13/20250.02 EUR
8/12/20250.03 EUR
8/11/20250.03 EUR
8/8/20250.03 EUR
8/7/20250.03 EUR
8/6/20250.03 EUR
Access this data via the Eulerpool API
Get Free API Key

Oxurion Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
3.95 M EUR
-35.28 M EUR
-51.83 M EUR
Jan 1, 2020
2.08 M EUR
-28.50 M EUR
-28.01 M EUR
Jan 1, 2021
1.13 M EUR
-27.37 M EUR
-29.16 M EUR
Jan 1, 2022
595,000.00 EUR
-21.95 M EUR
-31.69 M EUR
Jan 1, 2023
263,000.00 EUR
-11.98 M EUR
-18.97 M EUR
Jan 1, 2024
3,000.00 EUR
382,000.00 EUR
119,000.00 EUR
Jan 1, 2025 (e)
0.00 EUR
-18.98 M EUR
-499,994.07 EUR
Jan 1, 2026 (e)
0.00 EUR
-7.71 M EUR
-92,134.16 EUR

Oxurion Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 6, 2026, 4:22 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
SHARESM
201120122013201420152016201720182019202020212022202320242025e2026e
2.0075.00112.0013.0011.007.009.005.003.002.001.00–––––
-66.673,650.0049.33-88.39-15.38-36.3628.57-44.44-40.00-33.33-50.00–––––
100.0096.0094.6469.2363.6414.2966.6720.0033.3350.00100.00–––––
2.0072.00106.009.007.001.006.001.001.001.001.001.001.001.001.001.00
-24.0029.0025.00-52.00-38.00-34.0023.00-39.00-35.00-28.00-27.00-21.00-11.00–-18.00-7.00
-1,200.0038.6722.32-400.00-345.45-485.71255.56-780.00-1,166.67-1,400.00-2,700.00–––––
-21.0030.0026.00-51.00-37.00-60.0022.00-38.00-51.00-28.00-29.00-31.00-18.00–––
61.54-242.86-13.33-296.15-27.4562.16-136.67-272.7334.21-45.103.576.90-41.94–––
32.4035.0036.9036.1036.0936.0936.6038.2539.4139.23–0.010.173.193.193.19
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Oxurion generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Oxurion retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Oxurion's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Oxurion has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Oxurion's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Oxurion stock margins

The Oxurion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Oxurion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Oxurion.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
42.75 %
-894.15 %
-1,313.41 %
Jan 1, 2020
73.53 %
-1,371.27 %
-1,348.03 %
Jan 1, 2021
45.74 %
-2,426.24 %
-2,584.93 %
Jan 1, 2022
13.78 %
-3,688.40 %
-5,325.21 %
Jan 1, 2023
39.54 %
-4,555.89 %
-7,212.55 %
Jan 1, 2024
-1,333.33 %
12,733.33 %
3,966.67 %
Jan 1, 2025 (e)
-1,333.33 %
- %
- %
Jan 1, 2026 (e)
-1,333.33 %
- %
- %

Oxurion Stock Revenue, EBIT, Earnings per Share

The Oxurion earnings per share therefore indicates how much revenue Oxurion has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
0.10 EUR
-0.90 EUR
-1.31 EUR
Jan 1, 2020
0.05 EUR
-0.73 EUR
-0.71 EUR
Jan 1, 2021
296.84 EUR
-7,202.11 EUR
-7,673.16 EUR
Jan 1, 2022
70.00 EUR
-2,581.88 EUR
-3,727.65 EUR
Jan 1, 2023
1.59 EUR
-72.53 EUR
-114.82 EUR
Jan 1, 2024
0.00 EUR
0.12 EUR
0.04 EUR
Jan 1, 2025 (e)
0.00 EUR
-5.95 EUR
-0.16 EUR
Jan 1, 2026 (e)
0.00 EUR
-2.42 EUR
-0.03 EUR

Oxurion business model & stock analysis

Oxurion Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Oxurion historical P/E ratio, EBIT multiple, and P/S ratio

Oxurion annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Oxurion shares outstanding

The number of shares of Oxurion was 3.19 M in 2025. This indicates how many shares Oxurion is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
39.41 M Stocks
Jan 1, 2020
39.23 M Stocks
Jan 1, 2021
3,800.00 Stocks
Jan 1, 2022
8,500.00 Stocks
Jan 1, 2023
165,200.00 Stocks
Jan 1, 2024
3.19 M Stocks
Jan 1, 2025 (e)
3.19 M Stocks
Jan 1, 2026 (e)
3.19 M Stocks

Oxurion stock splits

In Oxurion's history, there have been no stock splits.

Current Oxurion forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
0.00 % (0)
Hold
33.33 % (3)
Sell
66.67 % (6)
12M Price Target
0.27
Last Price
0.00
Currency
EUR
12M Return Potential
10,100.00 %
LTM Return
0 %

Oxurion Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/24/2023-0.37EUR-0.00EUR-2022 Q4
9/7/2022-0.40EUR-0.00EUR-2022 Q2
2/22/2022-0.43EUR-81,199.00EUR-2021 Q4
9/9/2021-0.44EUR-0.00EUR-2021 Q2

EESG©

Eulerpool ESG Scorecard© for the Oxurion stock

48/100
16
Environment
95
Social
32
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Oxurion shareholder structure

% Name
198.52588%
Atlas Special Opportunities LLC
Atlas Special Opportunities LLC

Oxurion Executives and Management Board

6 members · 17 % women

PG

Mr. Pascal Ghoson

Chief Executive Officer, Chief Financial Officer, Executive Director - Permanent Representative of MARS SARL, Member of the Executive Committee · since 2023

280,000.00 EUR

Management

PB

Mr. Philippe Barbeaux

Chief Scientific Officer, Member of the Executive Committee

–
AD

Dr. Andy De Deene

Chief Development Officer, Member of the Executive Committee · since 2020

–

Board of Directors

CB

Mr. Charles De Bollardiere

Non-Executive Independent Chairman of the Board

15,000.00 EUR
JH

Mr. James Hartmann

Non-Executive Independent Director

10,000.00 EUR
NS

Ms. Nelly Souleymane

Non-Executive Independent Director

–

Frequently asked questions about Oxurion

Analysts currently set an average price target of 0.27 EUR for the Oxurion stock (median: 0.27 EUR), implying +10,100.0 % versus the latest price. The consensus is based on 9 analyst ratings.

Oxurion Analyst Price Targets 2026

9 analysts currently rate the Oxurion stock: 0 recommend buying, 3 holding and 6 selling.

Oxurion Analyst Price Targets 2026

The Oxurion share (OXUR.BR) is listed on 7 stock exchanges, including: Frankfurt (TG4.F), Düsseldorf (TG4.DU), London (0G99.L), London (0G99.L), SIX (Zürich) (THR.SW).

No history available for Oxurion.

The revenue cannot currently be calculated for Oxurion.

The expected profit of Oxurion is -92,134.16 EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Oxurion is currently -0.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Oxurion stock.

The P/S cannot be calculated for Oxurion currently.

The Eulerpool Quality Score for Oxurion is 2/10.

The ISIN of Oxurion is BE0974487192. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Oxurion is A0J30B. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Oxurion is OXUR.BR. The ticker symbol is used to trade Oxurion shares on the stock exchange.

Oxurion paid dividends every year for the past 0 years.

Oxurion is assigned to the 'Health' sector.

The dividends of Oxurion are distributed in EUR.

All fundamentals and in-depth analysis of Oxurion

Our stock analysis for Oxurion stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oxurion. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Oxurion Stock
Oxurion Revenue→
Oxurion Stock
Oxurion Net Income→
Oxurion Stock
Oxurion P/E→
Oxurion Stock
Oxurion P/S→
Oxurion Stock
Oxurion EBIT→
Oxurion Stock
Oxurion Dividend→
Oxurion Stock
Oxurion Directors Dealings→
Oxurion Stock
Oxurion Stocks→
Oxurion Stock
Oxurion Market capitalization→
Oxurion Stock
Oxurion Debt→
Oxurion Stock
Oxurion Liabilities→
Oxurion Stock
Oxurion Equity→
Oxurion Stock
Oxurion AAQS→
Oxurion Stock
Oxurion Employees→
Oxurion Stock
Oxurion ROE→
Oxurion Stock
Oxurion ROA→
Oxurion Stock
Oxurion ROCE→
Oxurion Stock
Oxurion News→
Oxurion Stock
Oxurion Analyst Price Targets→

Health Stocks

P&K Skin Research Center CoOxford Nanopore TechnologiesP&S Robotics CoOxford BiomedicaP3 Health PartnersOxford BiodynamicsPacific Biosciences of CaliforniaOwletPacific EdgeOvid TherapeuticsPacific Health Care OrganizationOutset MedicalAll Stocks A–Z →